Christopher B. Granger
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac electrophysiology and arrhythmias
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Acute Myocardial Infarction Research 252
- Atrial Fibrillation Management and Outcomes 186
- Heart Failure Treatment and Management 66
- Antiplatelet Therapy and Cardiovascular Diseases 59
- Surgery 88
- Coronary Interventions and Diagnostics 42
- Co-authors
- Salim Yusuf (83 shared papers)John J.V. McMurray (91 shared papers)Karl Swedberg (55 shared papers)Marc A. Pfeffer (67 shared papers)Eric L. Michelson (41 shared papers)Jan Östergren (18 shared papers)Bertil Olofsson (19 shared papers)Peter Held (5 shared papers)
- Journals
- American Heart Journal (137 papers)Journal of the American College of Cardiology (132 papers)Circulation (98 papers)European Heart Journal (62 papers)The American Journal of Cardiology (44 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Christopher B. Granger
843 papers receiving 63.7k citations
Christopher B. Granger's Hit Papers
Peers
Comparison fields: 5 of 195
- Cardiology and Cardiovascular Medicine 40.6k
- Internal Medicine 4.8k
- Emergency Medicine 3.2k
- Family Practice 611
- Radiology, Nuclear Medicine and Imaging 5.9k
Countries citing papers authored by Christopher B. Granger
This map shows the geographic impact of Christopher B. Granger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Granger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Granger more than expected).
Fields of papers citing papers by Christopher B. Granger
This network shows the impact of papers produced by Christopher B. Granger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Granger. The network helps show where Christopher B. Granger may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher B. Granger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 877 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2159 |
| 2 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 1898 |
| 3 | Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events Hit paper breakdown → | 2003 | 1721 |
| 4 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1417 |
| 5 | 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Hit paper breakdown → | 2018 | 1269 |
| 6 | Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety Hit paper breakdown → | 2001 | 1223 |
| 7 | A Validated Prediction Model for All Forms of Acute Coronary Syndrome Hit paper breakdown → | 2004 | 1218 |
| 8 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1210 |
| 9 | Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) Hit paper breakdown → | 2006 | 1161 |
| 10 | Embolic strokes of undetermined source: the case for a new clinical construct Hit paper breakdown → | 2014 | 1118 |
| 11 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Hit paper breakdown → | 2016 | 1107 |
| 12 | Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Hit paper breakdown → | 2013 | 1011 |
| 13 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Hit paper breakdown → | 2016 | 932 |
| 14 | Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia Hit paper breakdown → | 1996 | 892 |
| 15 | Heparin and Low-Molecular-Weight Heparin Hit paper breakdown → | 1998 | 856 |
| 16 | Predictors of mortality and morbidity in patients with chronic heart failure Hit paper breakdown → | 2005 | 772 |
| 17 | Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure Hit paper breakdown → | 2007 | 762 |
| 18 | Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure Hit paper breakdown → | 2006 | 758 |
| 19 | Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006 Hit paper breakdown → | 2007 | 641 |
| 20 | Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients Hit paper breakdown → | 2005 | 624 |
About Christopher B. Granger
Christopher B. Granger is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Emergency Medicine and Internal Medicine, having authored 877 papers that have together received 66.8k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (252 papers), Atrial Fibrillation Management and Outcomes (186 papers), Heart Failure Treatment and Management (66 papers), Cardiac Imaging and Diagnostics (60 papers), Antiplatelet Therapy and Cardiovascular Diseases (59 papers), Cardiac Arrest and Resuscitation (58 papers), Venous Thromboembolism Diagnosis and Management (52 papers) and Coronary Interventions and Diagnostics (42 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (40.6k citations), Internal Medicine (4.8k citations), Emergency Medicine (3.2k citations), Family Practice (611 citations) and Radiology, Nuclear Medicine and Imaging (5.9k citations). Christopher B. Granger has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Salim Yusuf, John J.V. McMurray, Karl Swedberg, Marc A. Pfeffer, Eric L. Michelson, Jan Östergren, Bertil Olofsson, Peter Held, Paul W. Armstrong and Eric J. Topol. Their work appears in journals such as American Heart Journal, Journal of the American College of Cardiology, Circulation, European Heart Journal and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.